These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2852570)

  • 1. Diabetic nephropathy in the rat: differing renal effects of an angiotensin converting enzyme inhibitor and a calcium inhibitor.
    Whitty MR; Jackson B
    Diabetes Res; 1988 Jun; 8(2):91-6. PubMed ID: 2852570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat.
    Jackson B; Cubela R; Debrevi L; Whitty M; Johnston CI
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S167-9. PubMed ID: 2455124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage.
    Perico N; Amuchastegui CS; Malanchini B; Bertani T; Remuzzi G
    Exp Nephrol; 1994; 2(4):220-8. PubMed ID: 8069658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of angiotensin-converting enzyme inhibition in diabetic rats with reduced renal function.
    Geiger H; Bahner U; Vaaben W; Dammrich J; Heidland A; Luft FC
    J Lab Clin Med; 1992 Dec; 120(6):861-8. PubMed ID: 1453108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
    Volpini RA; da Silva CG; Costa RS; Coimbra TM
    Diabetes Metab Res Rev; 2003; 19(1):43-51. PubMed ID: 12592643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.
    Komers R; Schutzer W; Xue H; Oyama TT; Lindsley JN; Anderson S
    Transl Res; 2007 Dec; 150(6):343-9. PubMed ID: 18022596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of angiotensin converting enzyme inhibitor and calcium channel blocker on renal function of spontaneously hypertensive rat].
    Endo M
    Nihon Jinzo Gakkai Shi; 1991 Nov; 33(11):1161-72. PubMed ID: 1808367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effect of angiotensin-converting enzyme inhibitor enalapril in incipient diabetic nephropathy.
    Abu-Romeh SH; Nawaz MK; Ali JH; Al-Suhaili AR; Abu-Jayyab AK
    Clin Nephrol; 1989 Jan; 31(1):18-21. PubMed ID: 2536602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
    Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy.
    Björck S; Blohmé G; Sylvén C; Mulec H
    Nephrol Dial Transplant; 1997; 12 Suppl 2():67-70. PubMed ID: 9269704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal haemodynamics and function in weanling rats treated with enalapril from birth.
    Guron G
    Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):865-70. PubMed ID: 16173949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combination therapy with a calcium channel blocker and an angiotensin-converting enzyme inhibitor on renal hypertrophy and urinary albumin excretion in diabetic rats.
    Nielsen B; Grønbaek H; Osterby R; Flyvbjerg A
    Exp Diabesity Res; 2003; 4(3):191-9. PubMed ID: 15061647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of captopril and enalapril on the progression of chronic renal disease in partially nephrectomized rats.
    Fettman MJ; Wilke WL; VanHouten DS; Hamar DW; Mikita DJ
    Res Commun Chem Pathol Pharmacol; 1989 Aug; 65(2):131-46. PubMed ID: 2555851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.
    Remuzzi A; Puntorieri S; Battaglia C; Bertani T; Remuzzi G
    J Clin Invest; 1990 Feb; 85(2):541-9. PubMed ID: 1688888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of temocapril, an angiotensin-converting enzyme inhibitor with preferential biliary excretion, on experimental diabetic nephropathy].
    Yanagisawa Y
    Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1095-102. PubMed ID: 7815741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of angiotensin converting enzyme inhibition to affect the course of chronic puromycin aminonucleoside nephropathy.
    Marinides GN; Groggel GC; Cohen AH; Cook T; Baranowski RL; Westenfelder C; Border WA
    Am J Pathol; 1987 Nov; 129(2):394-401. PubMed ID: 2823616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal effects of antihypertensive therapy in uninephrectomized diabetic rats.
    Gallego B; Flores O; López-Novoa JM; Pérez-Barriocanal F
    Res Exp Med (Berl); 1997; 197(4):199-209. PubMed ID: 9440138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.